Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1999 October; 92(10): 505–510.
PMCID: PMC1297389

Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993 Apr 10;306(6883):983–987. [PMC free article] [PubMed]
  • Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996 May 22;275(20):1571–1576. [PubMed]
  • Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, et al. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials. 1998 Aug;19(4):370–390. [PubMed]
  • Troisi E, Attanasio A, Matteis M, Bragoni M, Monaldo BC, Caltagirone C, Silvestrini M. Cerebral hemodynamics in young hypertensive subjects and effects of atenolol treatment. J Neurol Sci. 1998 Jul 15;159(1):115–119. [PubMed]
  • Cohen A, Bregman B, Agabiti Rosei E, Williams B, Dubourg O, Clairefond P, Brudi P, Gosse P, Guéret P. Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. J Hum Hypertens. 1998 Jul;12(7):479–483. [PubMed]
  • Wilson TW, Lacourcière Y, Barnes CC. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group. CMAJ. 1998 Sep 8;159(5):469–476. [PMC free article] [PubMed]
  • Lorimer AR, Lyons D, Fowler G, Petrie JC, Rothman MT. Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures. J Hum Hypertens. 1998 Jun;12(6):411–416. [PubMed]
  • Weir MR, Reisin E, Falkner B, Hutchinson HG, Sha L, Tuck ML. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. Am J Hypertens. 1998 Aug;11(8 Pt 1):914–920. [PubMed]
  • Scholze J, Stapff M. Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor. Br J Clin Pharmacol. 1998 Aug;46(2):169–172. [PMC free article] [PubMed]
  • Zannad F, Chati Z, Guest M, Plat F. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators. Am Heart J. 1998 Oct;136(4 Pt 1):672–680. [PubMed]
  • Hoglund C, Hutchinson HG. A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension. Int J Clin Pract. 1998 Jun;52(4):221–225. [PubMed]
  • Tedesco MA, Ratti G, Aquino D, Limongelli G, di Salvo G, Mennella S, Galzerano D, Iarussi D, Iacono A. Effects of losartan on hypertension and left ventricular mass: a long-term study. J Hum Hypertens. 1998 Aug;12(8):505–510. [PubMed]
  • Pepine CJ, Handberg-Thurmond E, Marks RG, Conlon M, Cooper-DeHoff R, Volkers P, Zellig P. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol. 1998 Nov;32(5):1228–1237. [PubMed]
  • Cifkova R, Peleska J, Hradec J, Rosolová H, Pintérová E, Zeman K, Oddou-Stock P, Thirlwell J, Botteri F. Valsartan and atenolol in patients with severe essential hypertension. J Hum Hypertens. 1998 Aug;12(8):563–567. [PubMed]
  • Hall WD, Reed JW, Flack JM, Yunis C, Preisser J. Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks. Arch Intern Med. 1998 Oct 12;158(18):2029–2034. [PubMed]
  • Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1998 Oct 15;82(8):961–965. [PubMed]
  • Girvin B, Johnston GD. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients. J Hypertens. 1998 Jul;16(7):1049–1054. [PubMed]
  • Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAMA. 1998 Oct 7;280(13):1168–1172. [PubMed]
  • Wallis EJ, Ramsay LE, Hettiarachchi J. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension. Clin Pharmacol Ther. 1998 Oct;64(4):439–449. [PubMed]
  • Risler T, Bohm R, Wetzchewald D, Nast HP, Koch HH, Stein G, Erley CM. A comparison of the antihypertensive efficacy and safety of felodipine IV and nifedipine IV in patients with hypertensive crisis or emergency not responding to oral nifedipine. Eur J Clin Pharmacol. 1998 Jun;54(4):295–298. [PubMed]
  • Bagatin J, Sardelić S, Pivac N, Polić S, Ljutic D, Rakic D, Naranca M, Bojić L, Kovacić Z, Rumboldt Z. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension. Int J Clin Pharmacol Res. 1998;18(2):73–78. [PubMed]
  • Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy. Int J Clin Pharmacol Ther. 1998 Aug;36(8):425–431. [PubMed]
  • Goldblatt H, Haas E, Klick RL, Lewis LV. The effect of main artery occlusion of one kidney on blood pressure of dogs. Proc Natl Acad Sci U S A. 1976 May;73(5):1722–1724. [PubMed]
  • Stanley JC. David M. Hume memorial lecture. Surgical treatment of renovascular hypertension. Am J Surg. 1997 Aug;174(2):102–110. [PubMed]
  • Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol. 1989 Mar;31(3):119–122. [PubMed]
  • Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994 Oct;24(4):622–629. [PubMed]
  • Kalra PA, Mamtora H, Holmes AM, Waldek S. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Q J Med. 1990 Oct;77(282):1013–1018. [PubMed]
  • Swartbol P, Thorvinger BO, Pärsson H, Norgren L. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol. 1992 Jul-Sep;11(3):195–199. [PubMed]
  • von Kemp K, van den Brande P, Peterson T, Waegeneers S, Scheerlinck T, Danau W, van Tussenbroek F, Debing E, Staelens I. Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol. 1997 Jun;16(2):114–122. [PubMed]
  • Zierler RE, Bergelin RO, Polissar NL, Beach KW, Caps MT, Cantwell-Gab K, Davidson RC, Strandness DE., Jr Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Arch Intern Med. 1998 Apr 13;158(7):761–767. [PubMed]
  • Missouris CG, Papavassiliou MB, Khaw K, Hall T, Belli AM, Buckenham T, MacGregor GA. High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant. 1998 Apr;13(4):945–948. [PubMed]
  • Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992 May;2(11):1608–1616. [PubMed]
  • Uzu T, Inoue T, Fujii T, Nakamura S, Inenaga T, Yutani C, Kimura G. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis. 1997 May;29(5):733–738. [PubMed]
  • Missouris CG, Buckenham T, Vallance PJ, MacGregor GA. Renal artery stenosis masquerading as congestive heart failure. Lancet. 1993 Jun 12;341(8859):1521–1522. [PubMed]
  • Palmar AH, Defeyter IR, Vandenbogaerde JF. Renal arterial stenosis as a cause of high output cardiac failure. Int J Cardiol. 1989 Mar;22(3):404–406. [PubMed]
  • MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998 Jul 4;352(9121):13–16. [PubMed]
  • Navar LG. Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol. 1998 Mar;274(3 Pt 2):F433–F444. [PubMed]
  • Maher ER, Othman S, Frankel AH, Sweny P, Moorhead JF, Hilson AJ. Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant. 1988;3(5):608–611. [PubMed]
  • Kawamura J, Okada Y, Nishibuchi S, Yoshida O. Transient anuria following administration of angiotensin I-converting enzyme inhibitor (SQ 14225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation. J Urol. 1982 Jan;127(1):111–113. [PubMed]
  • Konrads A, Meurer KA, Hummerich W, Wambach G, Kindler J, Feltkamp H, Helber A. Antihypertensive effects of captopril and saralasin in essential and renal hypertension. Am J Cardiol. 1982 Apr 21;49(6):1558–1560. [PubMed]
  • Holm EA, Randløv A, Strandgaard S. Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis. Blood Press. 1996 Nov;5(6):360–362. [PubMed]
  • Ostermann M, Goldsmith DJ, Doyle T, Kingswood JC, Sharpstone P. Reversible acute renal failure induced by losartan in a renal transplant recipient. Postgrad Med J. 1997 Feb;73(856):105–107. [PMC free article] [PubMed]
  • Missouris CG, Ward DE, Eastwood JB, MacGregor GA. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney. Heart. 1997 Apr;77(4):391–392. [PMC free article] [PubMed]
  • Kothari SS, Sharma S, Sharma M, Saxena A. Enalapril-induced renal artery thrombosis in unilateral renal artery stenosis. Indian Heart J. 1997 Mar-Apr;49(2):192–194. [PubMed]
  • Scoble JE, Mikhail A, Reidy J, Cook GJ. Individual kidney function in atherosclerotic renal-artery disease. Nephrol Dial Transplant. 1998 Apr;13(4):1048–1049. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press